Horton, J.; Klarmann-Schulz, Ute; Stephens, M.; Budge, P. J.; Coulibaly, Y.; Debrah, A.; Debrah, L. B.; Yahathugoda, T. C.; Kroidl, I.; Deathe, D.; Majewski, A.; Sullivan, S.; Mackenzie, C.; Nutman, T. B.; Shott, J. P.; Weil, G.; Ottesen, E.; Hoerauf, A.
(BMC Part of Springer Nature, 2020-03-30)
Background
As new lymphatic filariasis infections are eliminated through mass chemotherapy, previously affected individuals are left with the sequellae, especially chronic progressive lymphoedema. Currently this is managed ...